NCT00920361View on ClinicalTrials.gov

Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED)

CompletedOBSERVATIONAL

Enrollment

1,664

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Fertilization in Vitro

Interventions

DRUG

Follitropin beta

Normally, Follistim Injection 150 or 225 IU will be administered (s.c. or i.m.) once a day for 4 days as follitropin beta (genetical recombination). The dosage will be adapted to growth of follicles (75-375 IU for 6-12 days, in general). If more than 3 follicles of mean diameter 16-20 mm are confirmed by ultrasound tomography, ovulation will be stimulated by using Human Chorionic Gonadotropin (hCG) drugs.

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00920361 - Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED) | Biotech Hunter | Biotech Hunter